 |
 Video: What is a Stock Split?
|
|
|
| China Biologic Products Holdings is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products, or plasma products, in China. All of Co.'s plasma products and the placenta polypeptide product are prescription medicines administered in the form of injections. Co.'s primary products are human albumin and immunoglobulin for intravenous injection (IVIG). Albumin has been used to treat critically ill patients by assisting the maintenance of adequate blood volume and pressure. IVIG is used for certain disease prevention and treatment by enhancing specific immunity. According to our China Biologic Products Holdings stock split history records, China Biologic Products Holdings has had 0 splits. | |
|
China Biologic Products Holdings (CBPO) has 0 splits in our China Biologic Products Holdings stock split history database.
Looking at the China Biologic Products Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into China Biologic Products Holdings shares, starting with a $10,000 purchase of CBPO, presented on a split-history-adjusted basis factoring in the complete China Biologic Products Holdings stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/20/2021 |
|
| Start price/share: |
$38.52 |
|
| End price/share: |
$119.99 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
211.50% |
|
| Average Annual Total Return: |
17.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$31,143.56 |
|
| Years: |
7.00 |
|
|
|
|
|
